News

Positive final 2-year topline data in completed DC vaccine Phase I/II trial in AML patients

SHOW RELEASE

Interim 1-year clinical immune monitoring data from DC vaccine trial in AML presented at ASH 2019 Annual Meeting

SHOW RELEASE

Medigene reports financial & business results for the first nine months of 2019

SHOW RELEASE

Immune monitoring data from phase I/II clinical trial with DC vaccines in AML to be presented at ASH conference

SHOW RELEASE

Medigene to present on neoantigens as targets for TCR-T cell-based therapies at 2019 SITC Annual Meeting

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Medigene highlights its 'iM (inducible Medigene)-TCR' approach at CAR-TCR Summit 2019 in Boston, USA

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Medigene reports financial & business results for the first six months of 2019

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Interim analysis from ongoing Phase I/II clinical trial with DC vaccines in AML patients presented at EHA

SHOW RELEASE

Medigene AG reports on Annual General Meeting 2019

SHOW RELEASE

Medigene announces clinical trial agreement for HA-1 TCR immunotherapy MDG1021 with University of Leiden

SHOW RELEASE

Medigene to present interim data analysis from Phase I/II DC-Vaccine trial at the EHA conference 2019

SHOW RELEASE

Medigene reports financial & business results for the first three months of 2019

SHOW RELEASE